But they should not be expected to produce results comparable to prescription weight loss medications
Clinical implication Although the association between GLP-1 RAs and gallbladder/biliary diseases has been supported by multiple studies, causality has not been definitively established
References Darwish R, Abu-Sharia G, Butler AE
For this reason, make sure you understand the costs of the GLP-1 weight loss medication, insurance coverage and expected results before starting it
Target dose levels and their clinical outcomes Clinical trials evaluated three primary maintenance dose levels: 4mg, 8mg, and 12mg weekly
[DOI] [PubMed] [Google Scholar] 24.Cannon C.P., Pratley R., Dagogo-Jack S., Mancuso J., Huyck S., Masiukiewicz U., Charbonnel B., Frederich R., Gallo S., Cosentino F., et al